Composition and Diversity of Intestinal Microbiota in Colorectal Cancer and Potential Utilization in Diagnosis and Therapy
),
(1) Department of Internal Medicine, Fatmawati General Hospital, Jakarta
Corresponding Author
Abstract
Colorectal cancer is the third most common malignancy and the fourth most common malignancy causing death in the world. The development of colorectal cancer is influenced by several factors, including external, internal environmental, and genetic factors. One of the environmental factors recently known to be associated with colorectal cancer is gut microbiota. Generally, gut microbiota has various functions and is influenced by several factors, such as food, drugs, activities, habits, and diseases. Microbiota may become imbalanced, otherwise known as dysbiosis, which may lead to several changes and disturbances that can initiate the development of malignancy. There were differences in the composition and diversity of the types of microbiota in colorectal cancer patients. This difference has the potential to be used as a diagnostic marker and also the development of treatment in patients with colorectal cancer.
Keywords: gut microbiota, colorectal cancer, diversity, abundance
References
Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017 Apr 1;66(4):683–91.
Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: Incidence, mortality, survival, and risk factors. Vol. 14, Przeglad Gastroenterologiczny. Termedia Publishing House Ltd.; 2019. p. 89–103.
Jeo W, Subrata F. The Survival Rate of Colorectal Cancer in dr. Cipto Mangunkusumo Hospital. The New Ropanasuri : Journal of Surgery [Internet]. 2020 Dec 18;5(2):13–7. Available from: https://scholarhub.ui.ac.id/nrjs/vol5/iss2/4/
Rebersek M. Gut microbiome and its role in colorectal cancer. Vol. 21, BMC Cancer. BioMed Central Ltd; 2021. p. 1325–38.
Abdullah M, Sukartini N, Nursyirwan SA, Pribadi RR, Maulahela H, Utari AP, et al. Gut Microbiota Profiles in Early-and Late-Onset Colorectal Cancer: A Potential Diagnostic Biomarker in the Future. Vol. 102, Digestion. S. Karger AG; 2021. p. 823–32.
Dominguez-Bello MG, Godoy-Vitorino F, Knight R, Blaser MJ. Role of the microbiome in human development. Gut. 2019 Jun 1;68(6):1108–14.
Kim J, Lee HK. Potential Role of the Gut Microbiome In Colorectal Cancer Progression. Vol. 12, Frontiers in Immunology. Frontiers Media S.A.; 2022. p. 1–10.
Song M, Chan AT, Sun J. Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer. Gastroenterology. 2020 Jan 1;158(2):322–40.
Kang M, Martin A. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development. Vol. 32, Seminars in Immunology. Academic Press; 2017. p. 3–13.
Wong SH, Zhao L, Zhang X, Nakatsu G, Han J, Xu W, et al. Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice. Gastroenterology. 2017 Dec 1;153(6):1621-1633.e6.
Quévrain E, Maubert MA, Michon C, Chain F, Marquant R, Tailhades J, et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii , a commensal bacterium deficient in Crohn’s disease. Gut. 2016 Mar;65(3):415–25.
Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, et al. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr. 2007 Feb 1;85(2):488–96.
Lee HA, Kim H, Lee KW, Park KY. Dead Nano-Sized Lactobacillus plantarum Inhibits Azoxymethane/Dextran Sulfate Sodium-Induced Colon Cancer in Balb/c Mice. J Med Food. 2015 Dec;18(12):1400–5.
Calatayud M, Van den Abbeele P, Ghyselinck J, Marzorati M, Rohs E, Birkett A. Comparative Effect of 22 Dietary Sources of Fiber on Gut Microbiota of Healthy Humans in vitro. Front Nutr. 2021 Jul 2;8(700571).
Sonnenburg JL, Bäckhed F. Diet-microbiota interactions as moderators of human metabolism. Vol. 535, Nature. Nature Publishing Group; 2016. p. 56–64.
Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Vol. 14, Nature Reviews Gastroenterology and Hepatology. Nature Publishing Group; 2017. p. 491–502.
Ramirez J, Guarner F, Bustos Fernandez L, Maruy A, Sdepanian VL, Cohen H. Antibiotics as Major Disruptors of Gut Microbiota. Front Cell Infect Microbiol. 2020 Nov 24;10(572912).
Patangia D V., Anthony Ryan C, Dempsey E, Paul Ross R, Stanton C. Impact of antibiotics on the human microbiome and consequences for host health. Microbiologyopen. 2022 Feb 1;11:e1260.
Imhann F, Jan Bonder M, Vich Vila A, Fu J, Mujagic Z, Vork L, et al. Proton pump inhibitors affect the gut microbiome. Gut. 2016;65:740–8.
Noh CK, Kim BS, Hong G, Cheong JY, Lee KJ. Effects of the administration of probiotics on fecal microbiota diversity and composition in healthy individuals. J Neurogastroenterol Motil. 2018;24(3):452–9.
Kim YS, Unno T, Kim BY, Park MS. Sex differences in gut microbiota. Vol. 38, World Journal of Men’s Health. Korean Society for Sexual Medicine and Andrology; 2020. p. 48–60.
D’Afflitto M, Upadhyaya A, Green A, Peiris M. Association between Sex Hormone Levels and Gut Microbiota Composition and Diversity - A Systematic Review. Vol. 56, Journal of Clinical Gastroenterology. Lippincott Williams and Wilkins; 2022. p. 384–92.
Monda V, Villano I, Messina A, Valenzano A, Esposito T, Moscatelli F, et al. Exercise modifies the gut microbiota with positive health effects. Oxid Med Cell Longev. 2017 Mar 5;2017:1–8.
Gong D, Gong X, Wang L, Yu X, Dong Q. Involvement of Reduced Microbial Diversity in Inflammatory Bowel Disease. Gastroenterol Res Pract. 2016;2016:1–7.
Bamola V, Kapardar R, Lal B, Sharma A, Chaudhry R. A metagenomic assessment of gut microbiota in Indian colon cancer patients. J Cancer Res Ther. 2022 Jan 1;18(1):96–102.
Liu W, Zhang R, Shu R, Yu J, Li H, Long H, et al. Study of the Relationship between Microbiome and Colorectal Cancer Susceptibility Using 16SrRNA Sequencing. Biomed Res Int. 2020 Jan 30;2020:1–17.
Ahn J, Sinha R, Pei Z, Dominianni C, Wu J, Shi J, et al. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst. 2013 Dec 18;105(24):1907–11.
Hibberd AA, Lyra A, Ouwehand AC, Rolny P, Lindegren H, Cedgård L, et al. Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention. BMJ Open Gastroenterol [Internet]. 2017;4:e000145. Available from: http://bmjopengastro.bmj.com/
Yusuf F, Adewiah S, Syam AF, Fatchiyah F. Altered profile of gut microbiota and the level short chain fatty acids in colorectal cancer patients. J Phys Conf Ser. 2019 Jan 7;1146.
Ai D, Pan H, Li X, Gao Y, Liu G, Xia LC. Identifying Gut Microbiota Associated With Colorectal Cancer Using a Zero-Inflated Lognormal Model. Front Microbiol. 2019 Apr 24;10:826.
Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets T V., et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science (1979). 2018 Jan 5;359(6371):97–103.
Liang JQ, Wong SH, Szeto CH, Chu ES, Lau HC, Chen Y, et al. Fecal microbial DNA markers serve for screening colorectal neoplasm in asymptomatic subjects. J Gastroenterol Hepatol. 2021 Apr;36(4):1035–43.
Zhang H, Wu J, Ji D, Liu Y, Lu S, Lin Z, et al. Microbiome analysis reveals universal diagnostic biomarkers for colorectal cancer across populations and technologies. Front Microbiol. 2022 Nov 3;13:1005201.
Zwezerijnen-Jiwa FH, Sivov H, Paizs P, Zafeiropoulou K, Kinross J. A systematic review of microbiome-derived biomarkers for early colorectal cancer detection. Neoplasia (United States). 2023 Feb 1;36:100868.
Article Metrics
Abstract View
: 175 times
Download : 133 times
DOI: 10.24871/2522024%p
Refbacks
- There are currently no refbacks.
